Video Insights
Advertisement
Discussing the evolving role of selinexor in treatment of myeloproliferative neoplasms.
Watch as Dr. Viges and Dr. Mascarenhas explore strategies to enhance patient-centered care in MPN management.
Two experts discuss the role of surrogate end points in MPN clinical trials.
Dr. Patel discusses PFS and MRD negativity results from the CARTITUDE-4 trial of cilta-cel versus standard of care in MM.
Researchers have developed a new scoring system using one of the largest global cohorts of T-cell lymphoma patients.
Jeff P. Sharman, MD, discusses pivotal findings from the phase III BRUIN CLL-321 trial.
Advertisement
Dr. Callander discusses a study on selinexor, pomalidomide, and dexamethasone for relapsed or refractory myeloma.
Jeff P. Sharman, MD, explores unmet needs, prognosis, and novel treatments like pirtobrutinib in CLL.
The panel discussed novel targeted combinations in CNS lymphoma, such as BTK inhibitors in combination with IRAK inhibitors.
The panel, moderated by Grzegorz Nowakowski, MD, discussed how to manage methotrexate toxicity in CNS lymphoma.
The COMMANDS trial evaluated frontline luspatercept in transfusion-dependent patients with lower-risk MDS and anemia.
A database study has identified an association between disease stage at lymphoma diagnosis and time of Medicaid enrollment.
Moderated by Amer M. Zeidan, MBBS, a panel discusses the critical roles of patient fitness, genetics in AML treatment.
This expert panel shares insights into the latest advancements, clinical challenges in AML and more.
Gain valuable insights from leading experts as they explore how targeted therapies are shaping the future of AML management.
The panel moderated by Prithviraj Bose, MD, goes into detail on practical aspects of this agent's use in the clinic.
The expert panel moderated by Dr. Bose looks at noteworthy study work on use of this agent for anemia in myelofibrosis.
Empaneled experts describe their investigations of momelotinib in a continued discussion moderated by Prithviraj Bose, MD.
The expert panel moderated by Prithviraj Bose, MD, tells which research presented at the Meeting they found most exciting.
Esteemed experts provide valuable insights into the evolving myelofibrosis landscape and its implications for patient care.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.